New Developments in the Medical Management of Prostate Cancer
- Hormonal therapies for PCa yield similar outcomes. Tennant, Scott // Urology Times;Feb2002, Vol. 30 Issue 2, p22
Reports the relationship between the outcomes of primary hormonal therapy and endocrine-related quality-of-life for prostate cancer treatment in Bethesda, Maryland. Inference to the data from the National Cancer Institute; Similarity of sexual function outcomes among orchiectomy patients;...
- Concurrent palliative care reduced symptom burden in prostate cancer. // Hem/Onc Today;3/25/2011, Vol. 12 Issue 6, p22
The article reports on the improved outcomes produced by symptom co-management delivered with oncologic or surgical care for men with prostate cancer, which is based on a study presented at the annual assembly of the American Academy of Hospice and Palliative Medicine (AAHPM) in the U.S. in 2011.
- Minerva. // BMJ: British Medical Journal (International Edition);10/10/98, Vol. 317 Issue 7164, p1024
Presents news items pertaining to health in Great Britain. Explanation on why outpatients fail to keep clinic appointments according to an article in the `International Journal of Clinical Practice'; Effects of PC-SPES in patients with prostate cancer; Suggestion for melting fat free cheese;...
- Degarelix not good value for money for the UK NHS. // PharmacoEconomics & Outcomes News;9/17/2011, Issue 637, p7
The article reports on a study, published in the "British Journal of Urology," which revealed that degarelix may not be cost-effective in comparison to triptorelin and antiandrogen therapy for treating patients with advanced hormone-dependent prostate cancer in Great Britain.
- Impact of new technology on costs for prostate cancer. // PharmacoEconomics & Outcomes News;4/2/2011, Issue 625, p6
The article discusses research on the utilization and cost of surgical and radiation treatments for prostate cancer, by P. L. Nguyen and colleagues, published in the "Journal of Clinical Oncology."
- Health Committee prostate cancer recommendations find favour with the Government. // New Zealand Doctor;8/10/2011, p27
The article reports that the New Zealand government will probably quickly implement majority of the Health Committee's recommendations to improve the early detection and treatment of prostate cancer. According to the author, the Health Committee is also calling for the establishment of a quality...
- CME Questions. // Clinical Oncology Alert;Aug2008, Vol. 24 Issue 8, p63
A quiz concerning medical treatments and information about breast and prostate cancer is presented.
- Observation best for low-risk prostate cancer? // PharmacoEconomics & Outcomes News;7/1/2013, Issue 682, p8
The article discusses a research on low-risk prostate cancer in men, in reference to the study "Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis," by J. H. Hayes, et al, published in the June 18, 2013 issue of "Annals of...
- Health-related quality of life in men with prostate cancer. Litwin, M S; Penson, D F // Prostate Cancer & Prostatic Diseases;1998, Vol. 1 Issue 5, p228
Focuses on the task of maintaining and improving health related quality of life (HRQOL) in the management of prostate cancer. Principal challenge of assessing HRQOL; Established instruments for HRQOL; Discussion on the prostate-specific domains of HRQOL.